Literature DB >> 9870815

"En-bloc" vertebrectomy in the mobile lumbar spine.

R F Heary1, A R Vaccaro, J Benevenia, J M Cotler.   

Abstract

BACKGROUND: Primary tumors of the vertebral bodies have previously been treated with total or subtotal excision in a piecemeal fashion (intralesional excision). Radiation therapy has been used to help control tumor growth. Recurrence rates with an intralesional, piecemeal removal of vertebral tumors have been unacceptably high. This study describes a method to excise a lumbar vertebra "en-bloc," and in the process, to perform a marginal (extralesional) resection of a primary tumor of the mobile lumbar spine that allows for a potential surgical cure.
METHODS: A combined posterior-anterior procedure allows for an extralesional, marginal resection of the tumor and the involved vertebra. All posterior bony elements, including the pedicles and the adjacent intervertebral discs, are removed via a posterior approach. An anterior, retroperitoneal approach is then used to remove the vertebral body/tumor as a single specimen. The nerve roots at the involved levels are spared and the spine is instrumented and fused both posteriorly and anteriorly.
RESULTS: Three patients successfully had combined posterior-anterior resections of lumbar vertebral chordomas. No permanent neurological complications occurred. Overall morbidity of the procedure was acceptable. At 31-month follow-up, no tumor recurrence has been detected.
CONCLUSIONS: "En-bloc" resection of a primary vertebral tumor of the lumbar spine is technically demanding, but potentially curative. The alternative approaches-intralesional excision, radiation therapy, or a combination-are unable to cure these tumors. Long-term, 10-year follow-up will be necessary to confirm whether this en-bloc approach provides a surgical cure.

Entities:  

Mesh:

Year:  1998        PMID: 9870815     DOI: 10.1016/s0090-3019(98)00078-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  Morphometric effects of acute shortening of the spine: the kinking and the sliding of the cord, response of the spinal nerves.

Authors:  Kadir Bahadir Alemdaroğlu; Doğan Atlihan; Oğuzhan Cimen; Cem Yalin Kilinç; Serkan Iltar
Journal:  Eur Spine J       Date:  2007-02-14       Impact factor: 3.134

2.  Expert's comment concerning Grand Rounds case entitled "a novel 'pelvic ring augmentation construct' for lumbo-pelvic reconstruction in tumor surgery" (by Sathya Thambiraj, Daren Forward, James Thomas and Bronek Boszczyk).

Authors:  Rahul Vaidya
Journal:  Eur Spine J       Date:  2012-04-04       Impact factor: 3.134

3.  En bloc resection of a C4 chordoma: surgical technique.

Authors:  Yoseph Leitner; Shay Shabat; Luca Boriani; Stefano Boriani
Journal:  Eur Spine J       Date:  2007-08-23       Impact factor: 3.134

4.  [Solitary spinal metastases. Is aggressive surgical management justified?].

Authors:  C Druschel; A C Disch; M Pumberger; P Schwabe; I Melcher; N P Haas; K-D Schaser
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

5.  L4 and L5 spondylectomy for en bloc resection of giant cell tumor and review of the literature.

Authors:  David R Santiago-Dieppa; Lee S Hwang; Ali Bydon; Ziya L Gokaslan; Edward F McCarthy; Timothy F Witham
Journal:  Evid Based Spine Care J       Date:  2014-10

6.  Total en bloc spondylectomy for L2 chordoma: a case report.

Authors:  Norimitsu Wakao; Shiro Imagama; Zenya Ito; Kei Ando; Kenichi Hirano; Ryoji Tauchi; Akio Muramoto; Hiroki Matsui; Tomohiro Matsumoto; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

7.  The Clinical Characteristics and Prediction Nomograms for Primary Spine Malignancies.

Authors:  Lei Zhou; Runzhi Huang; Ziheng Wei; Tong Meng; Huabin Yin
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

8.  Results following surgical resection of recurrent chordoma of the spine: experience in a single institution.

Authors:  Pongsthorn Chanplakorn; Thamrong Lertudomphonwanit; Wittawat Homcharoen; Prakrit Suwanpramote; Wichien Laohacharoensombat
Journal:  World J Surg Oncol       Date:  2020-08-27       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.